Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation | Zendy

Abhinav Sharma | Zendy; Ziad Hijazi | Zendy; Ulrika Andersson | Zendy; Sana M. AlKhatib | Zendy; Renato D. Lópes | Zendy; John H. Alexander | Zendy; Claes Held | Zendy; Elaine M. Hylek | Zendy; Sergio Leonardi | Zendy; Michael G. Hanna | Zendy; Justin A. Ezekowitz | Zendy; Agneta Siegbahn | Zendy; Christopher B. Granger | Zendy; Lars Wallentin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

Author(s) -

Abhinav Sharma,

Ziad Hijazi,

Ulrika Andersson,

Sana M. AlKhatib,

Renato D. Lópes,

John H. Alexander,

Claes Held,

Elaine M. Hylek,

Sergio Leonardi,

Michael G. Hanna,

Justin A. Ezekowitz,

Agneta Siegbahn,

Christopher B. Granger,

Lars Wallentin

Publication year - 2018

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.118.034125

Subject(s) - medicine , atrial fibrillation , cardiology , apixaban , stroke (engine) , heart failure , troponin , hazard ratio , natriuretic peptide , cause of death , troponin t , sudden death , myocardial infarction , sudden cardiac death , warfarin , rivaroxaban , disease , mechanical engineering , confidence interval , engineering

Atrial fibrillation is associated with an increased risk of death. High-sensitivity troponin T, growth differentiation factor-15, NT-proBNP (N-terminal pro-B-type natriuretic peptide), and interleukin-6 levels are predictive of cardiovascular events and total cardiovascular death in anticoagulated patients with atrial fibrillation. The prognostic utility of these biomarkers for cause-specific death is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research